Phase 1b study of R05137382/GC33 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) (NCT00976170) Meeting Abstract


Authors: Abou-Alfa, G. K.; Yen, C. J.; Carrasquillo, J. A.; Hsu, C. H.; Gansukh, B.; Ma, J.; Hollywood, E.; Wan, P. J.; Shao, Y. Y.; Lin, Z. Z.; Frenette, C.; O'Neil, B. H.; Schwartz, L. H.; Ohtomo, T.; Tanaka, T.; Chen, Y. C.; Ukrainskyj, S.; Saltz, L.; Lee, R.; Cheng, A. L.
Abstract Title: Phase 1b study of R05137382/GC33 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) (NCT00976170)
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613203263
PROVIDER: wos
Notes: Meeting Abstract: 4100 -- 50th Annual Meeting of the American-Society-of-Clinical-Oncology -- MAY 30-JUN 03, 2014 -- Chicago, IL -- S -- Source: Wos
MSK Authors
  1. Leonard B Saltz
    599 Saltz
  2. Ghassan Abou-Alfa
    229 Abou-Alfa
  3. Bolorsukh Gansukh
    15 Gansukh
  4. Jennifer Ma
    34 Ma
  5. Peter Justin Wan
    7 Wan